logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 19
  • 1
    Forsyth, Sally Ann, Dr
    Born in July 1962
    Individual (9 offsprings)
    Officer
    2018-03-05 ~ now
    OF - Director → CIF 0
  • 2
    Terlouw, Clare Elizabeth
    Head Of Corporate Developement born in December 1973
    Individual (13 offsprings)
    Officer
    2019-08-29 ~ 2023-01-11
    OF - Director → CIF 0
  • 3
    Hunter, Ann Jacqueline, Professor
    Born in November 1956
    Individual (18 offsprings)
    Officer
    2020-09-01 ~ now
    OF - Director → CIF 0
  • 4
    Allen, Dave
    Senior Vice President, Medicine Design born in July 1959
    Individual (1 offspring)
    Officer
    2016-01-01 ~ 2020-08-31
    OF - Director → CIF 0
  • 5
    Bouchet, Veronique Anne, Dr
    Pharmaceuticals Executive born in September 1959
    Individual (9 offsprings)
    Officer
    2012-05-01 ~ 2022-06-07
    OF - Director → CIF 0
  • 6
    Green, Jonathan Alexander
    Born in March 1957
    Individual (8 offsprings)
    Officer
    2019-08-30 ~ now
    OF - Director → CIF 0
  • 7
    Picardo, Martino
    Chief Executive Officer born in January 1960
    Individual (14 offsprings)
    Officer
    2011-03-01 ~ 2017-06-23
    OF - Director → CIF 0
  • 8
    Rivers, Graham Paul
    Born in May 1971
    Individual (12 offsprings)
    Officer
    2023-07-20 ~ now
    OF - Director → CIF 0
  • 9
    Drummond, Lynn, Dr
    Born in August 1959
    Individual (11 offsprings)
    Officer
    2023-05-01 ~ now
    OF - Director → CIF 0
  • 10
    Wheatcroft, James Russell
    Vp R&D Finance (Research & Mst) born in October 1967
    Individual (10 offsprings)
    Officer
    2020-09-01 ~ 2023-07-20
    OF - Director → CIF 0
  • 11
    Cooper, John
    Company Director born in September 1947
    Individual (8 offsprings)
    Officer
    2010-03-19 ~ 2016-07-05
    OF - Director → CIF 0
  • 12
    Rink, Timothy, Dr
    Consultant And Company Director born in August 1946
    Individual (1 offspring)
    Officer
    2010-07-30 ~ 2012-03-31
    OF - Director → CIF 0
  • 13
    Nelki, Daniel
    Solicitor born in September 1961
    Individual (4 offsprings)
    Officer
    2016-07-05 ~ 2017-04-05
    OF - Director → CIF 0
  • 14
    Baxter, Allan, Dr
    Svp Medicines Development born in February 1950
    Individual (11 offsprings)
    Officer
    2010-03-19 ~ 2015-01-06
    OF - Director → CIF 0
  • 15
    Ward, Iain Stuart
    Solicitor born in May 1971
    Individual (26 offsprings)
    Officer
    2017-04-05 ~ 2018-07-31
    OF - Director → CIF 0
  • 16
    Tomlinson, Ian Michael
    Pharmaceuticals Executive born in February 1969
    Individual (7 offsprings)
    Officer
    2011-08-15 ~ 2020-08-31
    OF - Director → CIF 0
  • 17
    Phadke, Uday Prabhakar, Dr
    Born in July 1952
    Individual (17 offsprings)
    Officer
    2023-04-03 ~ now
    OF - Director → CIF 0
  • 18
    GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
    - now 00835139
    GLAXO RESEARCH AND DEVELOPMENT LIMITED - 2001-12-20
    GLAXO GROUP RESEARCH LIMITED - 1994-01-01
    MATBURN RESEARCH LIMITED - 1978-12-31
    79, New Oxford Street, London, United Kingdom
    Active Corporate (36 parents, 1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 19
    THE WELLCOME TRUST LIMITED
    02711000
    Gibbs Building, 215, Euston Road, London, United Kingdom
    Active Corporate (55 parents, 25 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

STEVENAGE BIOSCIENCE CATALYST

Period: 2010-08-02 ~ now
Company number: 07196230
Registered names
STEVENAGE BIOSCIENCE CATALYST - now
Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
Brief company account
Average Number of Employees
172024-04-01 ~ 2025-03-31
172023-04-01 ~ 2024-03-31
Turnover/Revenue
4,091,025 GBP2024-04-01 ~ 2025-03-31
5,458,653 GBP2023-04-01 ~ 2024-03-31
Gross Profit/Loss
4,091,025 GBP2024-04-01 ~ 2025-03-31
5,458,653 GBP2023-04-01 ~ 2024-03-31
Administrative Expenses
-6,197,041 GBP2024-04-01 ~ 2025-03-31
-6,256,069 GBP2023-04-01 ~ 2024-03-31
Operating Profit/Loss
-986,341 GBP2024-04-01 ~ 2025-03-31
612,902 GBP2023-04-01 ~ 2024-03-31
Other Interest Receivable/Similar Income (Finance Income)
101,968 GBP2024-04-01 ~ 2025-03-31
121,431 GBP2023-04-01 ~ 2024-03-31
Profit/Loss on Ordinary Activities Before Tax
-884,373 GBP2024-04-01 ~ 2025-03-31
734,333 GBP2023-04-01 ~ 2024-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
201,195 GBP2024-04-01 ~ 2025-03-31
-120,441 GBP2023-04-01 ~ 2024-03-31
Profit/Loss
-683,178 GBP2024-04-01 ~ 2025-03-31
613,892 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
18,398,860 GBP2025-03-31
18,490,989 GBP2024-03-31
Fixed Assets
18,398,860 GBP2025-03-31
18,490,989 GBP2024-03-31
Debtors
Current
2,050,925 GBP2025-03-31
3,536,344 GBP2024-03-31
Cash at bank and in hand
1,544,048 GBP2025-03-31
2,109,056 GBP2024-03-31
Current Assets
3,594,973 GBP2025-03-31
5,645,400 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-3,402,997 GBP2025-03-31
Net Current Assets/Liabilities
191,976 GBP2025-03-31
1,926,739 GBP2024-03-31
Total Assets Less Current Liabilities
18,590,836 GBP2025-03-31
20,417,728 GBP2024-03-31
Creditors
Non-current, Amounts falling due after one year
-15,181,248 GBP2024-03-31
Net Assets/Liabilities
4,302,693 GBP2025-03-31
4,985,871 GBP2024-03-31
Equity
Retained earnings (accumulated losses)
4,302,693 GBP2025-03-31
4,985,871 GBP2024-03-31
Equity
4,302,693 GBP2025-03-31
4,985,871 GBP2024-03-31
Audit Fees/Expenses
24,250 GBP2024-04-01 ~ 2025-03-31
20,000 GBP2023-04-01 ~ 2024-03-31
Director Remuneration
390,472 GBP2024-04-01 ~ 2025-03-31
372,747 GBP2023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
Goodwill
25,275 GBP2025-03-31
25,275 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
25,275 GBP2025-03-31
25,275 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
11,682,564 GBP2025-03-31
11,609,127 GBP2024-03-31
Furniture and fittings
571,571 GBP2025-03-31
561,543 GBP2024-03-31
Computers
670,254 GBP2025-03-31
665,011 GBP2024-03-31
Other
1,642,621 GBP2025-03-31
404,887 GBP2024-03-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-2,000 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
8,591,411 GBP2025-03-31
7,755,152 GBP2024-03-31
Furniture and fittings
414,686 GBP2025-03-31
378,488 GBP2024-03-31
Computers
606,791 GBP2025-03-31
571,796 GBP2024-03-31
Other
245,337 GBP2025-03-31
245,337 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings, Owned/Freehold
36,198 GBP2024-04-01 ~ 2025-03-31
Computers, Owned/Freehold
34,995 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-2,000 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
3,091,153 GBP2025-03-31
3,853,975 GBP2024-03-31
Furniture and fittings
156,885 GBP2025-03-31
183,055 GBP2024-03-31
Computers
63,463 GBP2025-03-31
93,215 GBP2024-03-31
Other
1,397,284 GBP2025-03-31
159,550 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
36,084,501 GBP2025-03-31
34,758,059 GBP2024-03-31
Property, Plant & Equipment - Other Disposals
-2,000 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
17,685,641 GBP2025-03-31
16,267,070 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
1,420,571 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-2,000 GBP2024-04-01 ~ 2025-03-31
Trade Debtors/Trade Receivables
Current
460,739 GBP2025-03-31
1,357,231 GBP2024-03-31
Other Debtors
Current
111,921 GBP2025-03-31
1,280,416 GBP2024-03-31
Prepayments/Accrued Income
Current
1,311,000 GBP2025-03-31
898,697 GBP2024-03-31
Amount of corporation tax that is recoverable
Current
167,265 GBP2025-03-31
Trade Creditors/Trade Payables
Current
845,258 GBP2025-03-31
954,864 GBP2024-03-31
Corporation Tax Payable
Current
167,231 GBP2024-03-31
Taxation/Social Security Payable
Current
73,817 GBP2025-03-31
168,259 GBP2024-03-31
Finance Lease Liabilities - Total Present Value
Current
32,592 GBP2025-03-31
Other Creditors
Current
76,664 GBP2025-03-31
5,921 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
2,374,666 GBP2025-03-31
2,422,386 GBP2024-03-31
Creditors
Current
3,402,997 GBP2025-03-31
3,718,661 GBP2024-03-31
Non-current
14,071,220 GBP2025-03-31
15,181,248 GBP2024-03-31
Net Deferred Tax Liability/Asset
-216,923 GBP2025-03-31
-250,609 GBP2024-03-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
33,686 GBP2024-04-01 ~ 2025-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
-216,923 GBP2025-03-31
-250,609 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
37,902 GBP2025-03-31
31,222 GBP2024-03-31
Between one and five year
6,249 GBP2025-03-31
20,573 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
44,151 GBP2025-03-31
51,795 GBP2024-03-31
  • STEVENAGE BIOSCIENCE CATALYST
    Info
    STEVENAGE BIOSCIENCE PARK - 2010-08-02
    Registered number 07196230
    Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX
    PRIVATE LIMITED COMPANY BY GUARANTEE WITHOUT SHARE CAPITAL USE OF 'LIMITED' EXEMPTION incorporated on 2010-03-19 (16 years 2 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-19
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.